RIPK2 inhibitor OD36

CAS No. 1638644-62-8

RIPK2 inhibitor OD36( OD36 | OD-36 | OD 36 )

Catalog No. M12475 CAS No. 1638644-62-8

RIPK2 inhibitor OD36 is a potent, specific, ATP-competitive inhibitor of RIPK2 with IC50 of 5.3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RIPK2 inhibitor OD36
  • Note
    Research use only, not for human use.
  • Brief Description
    RIPK2 inhibitor OD36 is a potent, specific, ATP-competitive inhibitor of RIPK2 with IC50 of 5.3 nM.
  • Description
    RIPK2 inhibitor OD36 is a potent, specific, ATP-competitive inhibitor of RIPK2 with IC50 of 5.3 nM, inhibits Tyr and Ser/Thr-directed activities of RIPK2; inhibits both RIPK2 tyrosine autophosphorylation as well as downstream NF-κB and MAPK signaling induced by MDP, downregulates a panel of RIPK2 kinase-dependent genes; reduces cellular infiltration in an in vivo MDP-induced peritonitis model; also shows high affinity for cyclin G-associated kinase (GAK) with Ki of 3.8 nM.
  • In Vitro
    OD36 also inhibits ALK2 and ALK2 R206H with IC50s of 47 and 22 nM, respevtively.OD36 shows activity against ALK1 with a KD of 90 nM.OD36 potently antagonize mutant ALK2 signaling and osteogenic differentiation.OD36 (0.1-1 μM; 24 h) efficiently inhibits BMP-6 (50 ng/mL)-induced p-Smad1/5 in KS483 cells.Preincubation of fibrodysplasia ossificans progressiva (FOP) endothelial colony-forming cells (ECFCs) with OD36 (0.5 μM) completely prevents the activation of Smad1/5 and gene targets ID-1 and ID-3 in response to activin A.Western Blot Analysis Cell Line:KS483 cells Concentration:0.1, 0.2, and 1 μM Incubation Time:Result:Inhibited BMP-6 induced p-Smad1/5.
  • In Vivo
    OD36 (6.25 mg/kg; i.p.; once) alleviates inflammation in an acute peritonitis mice model. Animal Model:C57BL/6 mice, muramyl dipeptide (MDP)-induced model of peritonitisDosage:6.25 mg/kg Administration:Intraperitoneal injection, 30 min prior to MDP Result:Inhibited the recruitment of inflammatory cells to the peritoneum, specifically that of neutrophils, and, to a lesser extent, lymphocytes. Decreased RIPK2-specific genes as well as inflammatory cytokine and chemokine gene expression.
  • Synonyms
    OD36 | OD-36 | OD 36
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1638644-62-8
  • Formula Weight
    330.772
  • Molecular Formula
    C16H15ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (100.76 mM)
  • SMILES
    ClC1=CC(C2=C3N=C(C=CN3N=C2)NCCOCCO4)=CC4=C1
  • Chemical Name
    (13Z,14E)-25-chloro-3,6-dioxa-9-aza-1(3,5)-pyrazolo[1,5-a]pyrimidina-2(1,3)-benzenacyclononaphane

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tigno-Aranjuez JT, et al. J Biol Chem. 2014 Oct 24;289(43):29651-64. 2. Asquith CRM, et al. J Med Chem. 2019 Feb 15. doi: 10.1021/acs.jmedchem.8b01213.
molnova catalog
related products
  • GSK-872

    GSK-872 (GSK 872) is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor.

  • CSLP43

    CSLP43 (RIPK2 inhibitor CSLP43) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 19.9 nM in ADPGlo assay.

  • Necroptosis-IN-1

    Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.